Therapeutic Potential of Nrf2 Activators in Streptozotocin-Induced Diabetic Nephropathy

Cited by (507)

Items 501–507 of 507

1. Long‐term blood glucose control via glucose‐activated transcriptional regulation of insulin analogue in type 1 diabetes mice
   Wanling Lu, Lifang Xie, Yanhan Zhang, Hong Zhi Gao, David Geng, Chunguang Xie, Ming Liu, Gang Wang · 2025 · Diabetes Obesity and Metabolism
2. A review of advances in the treatment of diabetic nephropathy by modulating intestinal flora with natural products of traditional Chinese medicine
   Tao Wang, Ming Chen, Jiwen Xu, Yuhang Qiao, Xinhui Huang, Xiaoming Yan, Fuli Zhang · 2025 · Frontiers in Pharmacology
3. Exploring the Mechanism of Diabetic Renal Injury and Traditional Chinese Medicine Diagnosis and Treatment Based on Gut Microbiota
   俊杰 罗 · 2025 · Advances in Clinical Medicine
4. Potential activities and action mechanisms of fucoxanthin for the prevention of ionizing radiation-induced chronic diseases
   Chae Young Moon, Sooyeun Lee, Seon-Chil Kim, Hyunju Kang · 2026 · Algal Research
5. Cell-state- and compartment-dependent PI3K/Akt redox signaling in chronic kidney disease: mechanisms and translational implications
   Jianzong Xuan, Renhua Ding, Haiyin Zhang, Yiyuan Wang, Lijuan Wu, Yuan Liu, Jianrui Dong, Ran Hu · 2026 · Frontiers in Pharmacology
6. Abietic acid attenuates hyperglycemia and oxidative stress via TLR4-mediated inflammation and PPAR-γ–Nrf2 activation: evidence from network pharmacology and in vivo validation
   Akash Mishra, Hital Shah · 2026 · In Silico Pharmacology
7. Linagliptin increases the expression of LRP2 independent of Nrf2 in streptozotocin‐induced diabetic mice
   Suratsawadee Promsuwan, Yumi Takiyama, Takao Takiyama, Yuri Takiyama, Hiroya Kitsunai, Hiroshi Nomoto · 2026 · Journal of Diabetes Investigation